KAYLA WUEBBELS: Open Payments
NPI 1417474511 · MARYVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,403 in 121 payments from 19 companies in 2025. Trend: 2023 $1,664 · 2024 $2,145 · 2025 $2,403
Food & beverage: $2,403
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $588 |
| ABBVIE INC. | 27 | $479 |
| PFIZER INC. | 13 | $206 |
| Corcept Therapeutics | 10 | $187 |
| Lilly USA, LLC | 12 | $184 |
| GlaxoSmithKline, LLC. | 10 | $137 |
| Abbott Laboratories | 4 | $85 |
| Novo Nordisk Inc | 4 | $78 |
| Exact Sciences Corporation | 5 | $77 |
| Aimmune Therapeutics, Inc. | 2 | $55 |
Products named: FARXIGA, VRAYLAR, Korlym, MOUNJARO, NURTEC ODT, AIRSUPRA, QULIPTA, REXULTI.
Industry payments across IL — which companies pay providers there.
